A Clinical Trial to Study the Efficacy and Safety of Stempeucel ® in Patients With CLI Due to Buergers Disease
Condition:   Critical Limb Ischemia Due to Buerger's Disease Intervention:   Biological: Stempeucel(R) Sponsor:   Stempeutics Research Pvt Ltd Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2017 Category: Research Source Type: clinical trials